The market opportunity lies in offering specialized training and consultancy services to pharmaceutical companies for navigating complex CMC regulatory requirements for biological drugs, ensuring ...

-- FDA Chemistry, Manufacturing, and Controls (CMC) Development and Readiness Pilot (CDRP) program supports manufacturing readiness for therapies with expedited clinical development timelines -- ...

Citius Pharmaceuticals Inc. appointed drug industry veteran Kelly Creighton as executive vice president of chemistry, manufacturing and controls, the company announced Nov. 5. Creighton will be ...

Dublin, April 14, 2026 (GLOBE NEWSWIRE)-- The "Digital CMC: The Key To Realising Pharma 4.0 (June 23, 2026)" training has been added to ResearchAndMarkets.com's offering. The pharmaceutical and ...

PHILADELPHIA--(BUSINESS WIRE)-- iECURE, Inc., a clinical-stage genome editing company developing variant-agnostic in vivo targeted gene insertion therapies for the treatment of severe, inherited, ...

SAN DIEGO--(BUSINESS WIRE)--Janux Therapeutics, a biopharmaceutical company developing novel T cell engager immunotherapies, today announced the appointment of Charles Winter as Senior Vice President ...

In January 2020, the Food and Drug Administration (FDA) issued a guidance entitled Chemistry, Manufacturing, and Control (CMC) Information for Human Gene Therapy Investigational New Drug Applications ...

Peptides, as essential biomolecules linking amino acids and proteins, play a vital role across numerous disciplines, including life science research, drug discovery, biomaterials engineering, and ...

Wugen Selected for U.S. FDA Chemistry, Manufacturing, and Controls Development and Readiness Pilot Program to Support Manufacturing Readiness of Soficabtagene Geleucel -- FDA Chemistry, Manufacturing, ...